M. T. Landi

1.5k total citations
21 papers, 816 citations indexed

About

M. T. Landi is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, M. T. Landi has authored 21 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in M. T. Landi's work include Carcinogens and Genotoxicity Assessment (5 papers), Toxic Organic Pollutants Impact (3 papers) and Air Quality and Health Impacts (2 papers). M. T. Landi is often cited by papers focused on Carcinogens and Genotoxicity Assessment (5 papers), Toxic Organic Pollutants Impact (3 papers) and Air Quality and Health Impacts (2 papers). M. T. Landi collaborates with scholars based in United States, Italy and France. M. T. Landi's co-authors include Neil E. Caporaso, Angela Cecilia Pesatori, Pier Alberto Bertazzi, Andrea Baccarelli, George W. Lucier, Margaret A. Tucker, Seymour Garte, C Graham Clark, Greg Cosma and Paula Shields and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, American Journal of Epidemiology and Environmental Health Perspectives.

In The Last Decade

M. T. Landi

20 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. T. Landi United States 15 341 260 209 166 98 21 816
Rosalynn Gill United States 13 334 1.0× 183 0.7× 235 1.1× 31 0.2× 26 0.3× 30 790
V. S. Turusov France 15 240 0.7× 287 1.1× 141 0.7× 192 1.2× 42 0.4× 55 802
Kari Hemminki Sweden 12 146 0.4× 212 0.8× 205 1.0× 70 0.4× 34 0.3× 16 594
Laurie Burdette United States 17 397 1.2× 202 0.8× 158 0.8× 53 0.3× 27 0.3× 24 762
Gaofeng Li China 13 283 0.8× 137 0.5× 304 1.5× 26 0.2× 25 0.3× 38 777
Nalini Chandar United States 17 408 1.2× 168 0.6× 251 1.2× 43 0.3× 21 0.2× 43 815
Lorraine Hart United Kingdom 10 318 0.9× 316 1.2× 176 0.8× 34 0.2× 15 0.2× 12 1.1k
Yoko Hirabayashi Japan 15 331 1.0× 209 0.8× 134 0.6× 89 0.5× 22 0.2× 57 942
Wayne S. Stillman United States 19 335 1.0× 441 1.7× 89 0.4× 183 1.1× 19 0.2× 37 940
Paula Shields United States 7 512 1.5× 306 1.2× 149 0.7× 49 0.3× 78 0.8× 16 723

Countries citing papers authored by M. T. Landi

Since Specialization
Citations

This map shows the geographic impact of M. T. Landi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. T. Landi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. T. Landi more than expected).

Fields of papers citing papers by M. T. Landi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. T. Landi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. T. Landi. The network helps show where M. T. Landi may publish in the future.

Co-authorship network of co-authors of M. T. Landi

This figure shows the co-authorship network connecting the top 25 collaborators of M. T. Landi. A scholar is included among the top collaborators of M. T. Landi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. T. Landi. M. T. Landi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Landi, M. T., Chiara Cremolini, Sara Lonardi, et al.. (2025). Switch from cetuximab to panitumumab during encorafenib-based therapy in BRAF V600E mutated metastatic colorectal cancer: An international multicenter analysis from the AGEO group. Clinics and Research in Hepatology and Gastroenterology. 50(1). 102746–102746.
2.
Landi, M. T., Michele Preti, Antonio Masetti, & Francesco Spinelli. (2024). Effect of the Localized Insecticides Spray Technique to Control Halyomorpha halys in Actinidia chinensis Orchards. Insects. 15(9). 723–723. 1 indexed citations
3.
Preti, Michele, et al.. (2018). Screening in open field and laboratory condition of pyrethroids insecticide activity against Halyomorpha halys in Emilia-Romagna.. 403–414. 2 indexed citations
4.
5.
Bodelón, Clara, Troy J. Kemp, Angela Cecilia Pesatori, et al.. (2013). Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancer. Annals of Oncology. 24(8). 2073–2079. 29 indexed citations
6.
Pesatori, Angela Cecilia, Michele Carugno, Dario Consonni, et al.. (2013). Hormone use and risk for lung cancer: a pooled analysis from the International Lung Cancer Consortium (ILCCO). British Journal of Cancer. 109(7). 1954–1964. 46 indexed citations
7.
Koshiol, Jill, Margaret L. Gulley, Yingdong Zhao, et al.. (2011). Epstein–Barr virus microRNAs and lung cancer. British Journal of Cancer. 105(2). 320–326. 23 indexed citations
8.
Rotunno, Melissa, Yiqiang Zhao, Andrew W. Bergen, et al.. (2010). Inherited polymorphisms in the RNA-mediated interference machinery affect microRNA expression and lung cancer survival. British Journal of Cancer. 103(12). 1870–1874. 41 indexed citations
9.
Bagnardi, Vincenzo, G. Randi, Jay H. Lubin, et al.. (2009). Alcohol Consumption and Lung Cancer Risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) Study. American Journal of Epidemiology. 171(1). 36–44. 43 indexed citations
10.
Baccarelli, Andrea, Angela Cecilia Pesatori, Dario Consonni, et al.. (2005). Health status and plasma dioxin levels in chloracne cases 20 years after the Seveso, Italy accident. British Journal of Dermatology. 152(3). 459–465. 45 indexed citations
11.
Baccarelli, Andrea, Donato Calista, Paola Minghetti, et al.. (2004). XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. British Journal of Cancer. 90(2). 497–502. 52 indexed citations
12.
Landi, M. T.. (2003). TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident. Carcinogenesis. 24(4). 673–680. 42 indexed citations
13.
Landi, M. T., Andrea Baccarelli, Robert E. Tarone, et al.. (2002). DNA Repair, Dysplastic Nevi, and Sunlight Sensitivity in the Development of Cutaneous Malignant Melanoma. JNCI Journal of the National Cancer Institute. 94(2). 94–101. 78 indexed citations
14.
Landi, M. T., Andrea Baccarelli, Donato Calista, et al.. (2001). Combined risk factors for melanoma in a Mediterranean population. British Journal of Cancer. 85(9). 1304–1310. 64 indexed citations
15.
Iaquinto, Gaetano, Nicola Giardullo, V. D’Onofrio, et al.. (2000). Antibody response to Helicobacter pylori CagA and heat-shock proteins in determining the risk of gastric cancer development. Digestive and Liver Disease. 32(5). 378–383. 19 indexed citations
16.
Landi, M. T., et al.. (1998). [Bis-chloromethyl ether and carcinogenesis of alkylating agents].. PubMed. 88(5). 347–55. 1 indexed citations
17.
Landi, M. T., Dario Consonni, D. Patterson, et al.. (1998). 2,3,7,8-Tetrachlorodibenzo-p-dioxin plasma levels in Seveso 20 years after the accident.. Environmental Health Perspectives. 106(5). 273–277. 66 indexed citations
18.
Landi, M. T., Carlo Zocchetti, Fred F. Kadlubar, et al.. (1996). Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.. PubMed. 5(9). 693–8. 55 indexed citations
19.
Landi, M. T., Pier Alberto Bertazzi, Paula Shields, et al.. (1994). Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics. 4(5). 242–246. 178 indexed citations
20.
Caporaso, Neil E., Peter G. Shields, M. T. Landi, et al.. (1992). The debrisoquine metabolic phenotype and DNA-based assays: implications of misclassification for the association of lung cancer and the debrisoquine metabolic phenotype.. Environmental Health Perspectives. 98. 101–105. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalynn Gill Breakdown of academic impact, for papers by V. S. Turusov Breakdown of academic impact, for papers by Kari Hemminki Breakdown of academic impact, for papers by Laurie Burdette Breakdown of academic impact, for papers by Gaofeng Li Breakdown of academic impact, for papers by Nalini Chandar Breakdown of academic impact, for papers by Lorraine Hart Breakdown of academic impact, for papers by Yoko Hirabayashi Breakdown of academic impact, for papers by Wayne S. Stillman Breakdown of academic impact, for papers by Paula Shields
Rankless by CCL
2026